Spotlight on Biotechnology : valuation challenges of early-stage companies. A case study on CRISPR Therapeutics AG and Allakos, Inc
Year of publication: |
[2021]
|
---|---|
Authors: | Montagna, Dennis Marco ; Fino, Emanuele ; Nocera, Giovanni ; Amendola, Antonio |
Publisher: |
[S.l.] : SSRN |
Subject: | Biotechnologie-Industrie | Biotechnology industry | Biotechnologie | Biotechnology | Risikokapital | Venture capital | Unternehmensfinanzierung | Corporate finance |
Extent: | 1 Online-Ressource (36 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments December 1, 2020 erstellt |
Other identifiers: | 10.2139/ssrn.3755675 [DOI] |
Classification: | G10 - General Financial Markets. General ; G11 - Portfolio Choice ; C81 - Methodology for Collecting, Estimating, and Organizing Microeconomic Data |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Initial public offering and financing of biotechnology start-ups : evidence from Japan
Honjō, Yūji, (2015)
-
Dewo, Setio Anggoro, (2005)
-
Dewo, Setio Anggoro, (2005)
- More ...
-
Analysis of Equity β Principal Components in Low Risk Framework : New Results and Prospectives
Amendola, Antonio, (2017)
-
Valuation Measures : From Simple Ratios to Stock Market’s Predictors
Sorge, Benedetta, (2021)
-
Advanced Valuation : Modelling DCF in Continuous Time
Montagna, Dennis Marco, (2023)
- More ...